Pharmacologic or genetic inactivation of Pim-1 enhances the growth inhibitory and pro-apoptotic effects of topoisomerase 2 inhibitors in FLT3-ITD cell lines and primary AML cells. The gene discussed is PIM1; the disease is acute myeloid leukemia.